- Home » News and EventsPage 25
NEWS & EVENTS
Our newest offerings and capabilities. Recent investments in network capacity, new and expanded services and expertise. Upcoming conferences and events.
Catalent To Present Scientific Innovations And Lead Drug Delivery Discussions At The Controlled Release Society Annual Meeting
Jul 10, 2019
Catalent today announced that Cornell Stamoran, Ph.D., founder of Catalent’s Applied Drug Delivery Institute, has been invited to chair multiple sessions at the upcoming CRS Annual Meeting and Exposition in Valencia, Spain.
Catalent’s Partner, Passage Bio, Announces New Dedicated Gene Therapy Manufacturing Suite
Jul 10, 2019
The dedicated cGMP suite is to be built under strategic partnership with Paragon Gene Therapy to support future clinical and commercial production for Passage Bio’s AAV-delivered gene therapies
Catalent Extends Global Commercial Spray Drying Capabilities In Europe
Jul 9, 2019
Catalent today announced that it has significantly expanded the capacity of its global spray drying operations through an agreement with Sanofi Active Ingredient Solutions, an industrial platform of Sanofi…
The Use Of Continuous Chromatography In Effective Process Design To Be Presented By Catalent Biologics Expert At PREP Symposium
Jul 2, 2019
Catalent today announced that Ben Kester, Manager and Senior Scientist, Purification Development, Catalent Biologics, will present at the upcoming 32nd International PREP Symposium.
Catalent’s Partner, Amicus, Announces It Has Entered Into A Strategic Partnership With Catalent For Gene Therapy Development And Manufacturing
Jul 2, 2019
The agreement supports clinical and commercial supply needs for Pompe and other lysosomal disease gene therapy programs
Ways Of Maximizing Value Through Collaborations To Be Discussed By Catalent At ON Helix
Jun 27, 2019
Catalent today announced that Rob Harris, Ph.D., Director, Science & Technology will present at the upcoming ON Helix conference to be held at the Babraham Research Campus, Cambridge, U.K. on July 9 – 10, 2019.
Novavax and Catalent Biologics Enter Strategic Partnership with Acquisition of Novavax’ Manufacturing Assets and Capabilities
Jun 27, 2019
Novavax, Inc. and Catalent Biologics’ Paragon Gene Therapy unit today announced an arrangement under which Paragon Gene Therapy will assume the leases to two Novavax product development and manufacturing facilities, giving it immediate access to state-of-the-art…
Catalent To Purchase Bristol-Myers Squibb Manufacturing Facility In Anagni, Italy
Jun 19, 2019
Bristol-Myers Squibb Company and Catalent, Inc. today announced that Catalent has agreed to purchase Bristol-Myers Squibb’s oral solid, biologics, and sterile product manufacturing and packaging facility in Anagni, Italy.
IVERIC Bio Enters Into Strategic Manufacturing Relationship With Catalent’s Paragon Gene Therapy For Orphan Inherited Retinal Diseases
Jun 17, 2019
IVERIC bio, Inc. and Catalent Biologics, today announced that they have entered into an agreement for production and manufacturing of GMP-grade adeno-associated virus vector for IVERIC bio’s gene therapy product candidates…
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.